8 October 2015
Time: 9:00am - 7:00pm
Alvaro Mata, Director of the Institute of Bioengineering
The public launch of QMUL’s Institute of Bioengineering (IoB) on Thursday 8 October will be marked with a day of presentations by distinguished leaders in the field and everyone at QMUL is invited to attend.
The IoB has just won a Royal Academy of Engineering Distinguished Visiting Fellowship to support the participation of the key note speaker, Professor Donald Ingber (Judah Folkman Professor of Vascular Biology and Bioengineering at Harvard and Director of the Wyss Institute, USA) at the event.
There will be several QMUL speakers, including Professor Simon Gaskell (Principal), who will give the welcome address, and there will be external speakers and senior guests from GSK, EPSRC, BBSRC, NC3Rs, Dr Hadwen Trust, Innovate UK, IMechE Biomedical Engineering Association Board, Nature, and Nature Biotechnology. Many companies will also be there as sponsors or participants.
As well as oral presentations and a panel discussion where you will be able to pose questions to the external speakers and guests, there will be poster presentations, a photo competition and opportunities to network during the coffee and lunch breaks and the wine reception at the end of the day. The event will be held in the Great Hall and Morris Lecture Theatre at Barts Hospital.
You can see a full list of speakers, the programme and register to attend the event at: https://www.eventbrite.co.uk/e/institute-of-bioengineering-launch-event-tickets-17454423651
The IoB plays an important role in the LSI, interacting with the other four research domains with its focus on ground-breaking research aimed at the development of new medical technologies to meet the key healthcare challenges of the 21st century.